BBIO Stock Ownership Activity

BRIDGEBIO PHARMA INC 13F holders

1 value investing guru has made changes to the BRIDGEBIO PHARMA INC (BBIO) position according to the gurus' latest SEC quarterly report(s). The number of BBIO shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying BBIO now?

According to the latest SEC filing(s) BRIDGEBIO PHARMA INC (BBIO) has not been purchased by any super investor.

To see more about who is investing in BRIDGEBIO PHARMA INC (BBIO), please go to the BBIO ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2025 Q1 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-12.20%
-3,065,616
-0.34%
2.42%
Current price: $38.62 11.72% Reported price*: $34.57
2023 Q3 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-5.63%
-1,155,000
-0.16%
2.08%
Current price: $38.62 46.45% Reported price*: $26.37
2019 Q2 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
buy
+26,221,676
+3.22%
3.17%
Current price: $38.62 43.20% Reported price*: $26.97
3 of 3

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.